U.S., Jan. 10 -- ClinicalTrials.gov registry received information related to the study (NCT07331259) titled 'CHART-C3G/CLNP023B12011' on Dec. 29, 2025.
Brief Summary: This is a non-interventional chart abstraction cohort study with longitudinal follow up. Patients with C3G treated with iptacopan will be enrolled and characterized (i.e., systematically describe and summarize) regarding their medical history and iptacopan use and evaluated for clinical events, outcomes, and laboratory measurements upon and after iptacopan treatment initiation. Medical charts will be used to obtain secondary pseudonymized patient-level data with reference to 2 time anchors: at index date (date of iptacopan treatment initiation) with baseline covering 12 month...